At Legacy DNA, we help mid-market healthtech and pharmacy leaders clarify, quantify, and communicate their value so buyers, partners, and investors instantly understand why they’re worth more.

We help you:

• Build a clear, defensible market position that commands premium multiples
• Craft a valuation-ready growth narrative that buyers believe and investors trust
• Align positioning, product, and proof so traction translates directly into enterprise value

Ready to turn clarity into traction? Book a Positioning & Valuation Diagnostic now and discover how premium buyers will really see your company.

When strong companies get undervalued

Even high-performing companies lose leverage when their story and strategy fall out of sync.

We help leadership teams correct:

• Valuation discounts when performance outpaces perception
• Message misalignment when marketing, sales, and leadership tell different stories
• Growth plateaus when revenue grows but enterprise value stalls
• Unleveraged proof when data and case studies aren’t packaged to influence acquirers, partners, or investors

Positioning isn’t a branding exercise. It’s a valuation lever that drives adoption, strengthens negotiating power, and accelerates premium exits.

Strategies built for healthcare growth

We don’t stop at messaging workshops or brand decks.

We build market positioning and valuation frameworks that connect product impact, buyer adoption, customer alignment, and investor confidence.

For companies preparing for an acquisition or recapitalization event, our Exit Readiness Sprint™ ensures your story, assets, and leadership narrative align with investor expectations early, before due diligence begins.

The positioning & valuation playbook

In as little as 90 days, we help your team:

• Define where you win and why buyers should pay a premium
• Sharpen your commercial story around data, differentiation, and defensible impact
• Package proof and traction into a narrative that accelerates both adoption and valuation

Then we stay engaged to ensure your positioning turns into momentum, not just a deck.

Market intelligence that defines opportunity

We combine qualitative and quantitative insight to create clarity and competitive advantage.

• Competitive landscape and white space opportunity mapping: See how key players position, price, and message their offerings, and identify where you can lead, not just compete
• Market sizing & segmentation: Quantify market potential, define high-value buyer segments, and uncover untapped growth opportunities to inform strategic expansion
• Revenue and valuation levers: Analyze the external forces, growth drivers, and market signals that most influence enterprise value and exit outcomes

“Clarity is commercial, not cosmetic. The companies that win category leadership don’t just out-innovate. They out-communicate.”— Dr. Roxie Mooney, CEO, Legacy DNA

Positioning that gains traction

• Category clarity: Define or redefine your market category so customers, partners, and investors "get it" fast
• Buyer messaging: Align your story with the decision-makers who control access, adoption, and revenue
• Adoption trigger strategy: Map the moments that move stakeholders from curiosity to commitment

“Positioning is the bridge between market potential and market performance.” — Harvard Business Review, 2024

A valuation-ready growth narrative

• Investor & acquirer lens: Connect your commercial performance to defensible, repeatable value creation
• Evidence packaging: Turn pilots, case studies, and clinical data into investor-grade proof that builds confidence
• Exit-readiness insight: Understand what premium buyers look for and build toward it now with our Premium Acquisition Sprint™

“Private equity firms and strategics alike are rewarding clarity. Companies with aligned commercial stories and data-driven proof see 20–30% higher valuation multiples at exit.” — PitchBook, 2025

Execution support for real market momentum

We don’t just hand off strategy.

Legacy DNA coaches leadership, sales, and marketing teams to unify narrative, accelerate adoption, and track progress that ties directly to valuation impact.

For sustained growth beyond the initial sprint, our Healthcare Growth Engine Partnership™ embeds commercialization leadership to ensure your positioning continues to drive adoption and enterprise value long after the first 90 days.

Let’s build momentum together

Turning late entrants into market leaders

Real-world impact: ParcelShield

When ParcelShield, an AI-enabled healthcare logistics company, entered the market, it faced a dominant competitor, limited visibility, and valuation skepticism.

Legacy DNA developed a unique and compelling brand story, market positioning, and value messaging that captured attention and created demand for the company’s solution. The repositioning transformed a late entrant into a formidable competitor. The shift was so significant that incumbent competitors united under one company, and together they became an attractive acquisition target for private equity.

The result:

• A 23% market share gain within 18 months
• A private equity acquisition that reshaped the healthcare logistics category

From clarity to market impact: How we build your growth story

Our process provides clarity, proof, and activation, giving buyers, partners, and investors a unified, credible reason to believe.

How the Process Works

1. Diagnose & Align – We identify what’s blocking growth and valuation through a market readiness diagnostic
2. Clarify Customers & Value – Define high-value audiences and craft narratives that resonate with buyers, partners, and investors
3. Build Your Market & Valuation Story – Shape your category, unify your brand narrative, and package the proof buyers expect
4. Activate & Scale – Deploy your positioning across GTM, sales, and investor communications to drive measurable traction and valuation

Tell a clear, compelling story that opens doors

Your team has built something extraordinary. It deserves to be valued that way. It needs a valuation strategy that strengthens credibility, expands market leadership, and commands premium multiples.

With Legacy DNA, you’ll:

• Turn market clarity into negotiating leverage
• Translate commercial performance into defensible valuation gains
• Build the narrative and assets that drive premium multiples at exit

Ready to command a premium exit?

Schedule your Valuation Strategy Call today